+1-206-701-6702
+44-020-8133-4027
+81-50-5539-1737
+91-848-285-0837
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Intravenous Solution Market – Insights
Intravenous solutions (IV) are administered in patients to provide sugar, salt and water directly into venous circulation. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and mixed solutions have become an integral part of modern therapy. Adoption of inorganic growth strategies such as collaborations and acquisitions by key players in order to expand their portfolio of intravenous solutions is expected to drive growth of the global intravenous solutions market. For instance, in April 2015, Baxter International Inc. and France-based Laboratoire Aguettant SAS, entered into a licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy.
The global intravenous solution market size was valued at US$ 8,372.0 million in 2019, and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027).
Global Intravenous Solution Market Share (%) Analysis, By Solution, 2019
Source: Coherent Market Insights Analysis (2019)
Increasing Launches and Regulatory Approvals for Intravenous Solution Injection is expected to Drive Growth of the Global Intravenous Solution Market
Increasing approvals for intravenous solution injections from regulatory authorities is expected to drive the global intravenous solution market growth over the forecast period. For instance, in 2015, B. Braun Medical Inc, a subsidiary of B.Braun, operating in infusion therapy and pain management, announced the U.S. FDA approval for its 70% Dextrose for Injection in a 2L flexible container. 70% Dextrose for Injection is an intravenous solution indicated as a source of calories and fluid replenishment.
Launches of new intravenous solution injections for the treatment of various diseases such as dehydration, gastrointestinal diseases is expected to drive the intravenous solution market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, offers medicines and technologies for infusion, transfusion, and clinical nutrition, launched Vecuronium Bromide for Injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis.
Intravenous Solution Market - Restraints
Growth of the global intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls of IV products. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.
Intravenous Solution Market- Regional Insights
On the basis of region, the global intravenous solution market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is expected to hold a dominant position in the global intravenous solution market over the forecast period, owing to increasing launches of parenteral (intravenous) nutrition (PN) products. For instance, in 2016, Baxter International Inc, a global leader in PN therapy, launched NUMETA G13E 300 mL in Europe. NUMETA G13E is the only ready-to-use parenteral (intravenous) nutrition (PN) product for preterm infants (less than 37 weeks gestation age).
Among region, Asia Pacific is expected to foresee a rapid growth in the intravenous solution market, owing to increasing launches of technologically advanced intravenous solutions by key players. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals, launched two intravenous IV products: Discport and Lifeport in the India drug market. The product is considered as smart intravenous infusion, which encompasses the latest technology that reduces the chances of any infection.
Global Intravenous Solution Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Source: Coherent Market Insights Analysis (2019)
Intravenous Solution Market - Competitive Landscape
Key players operating in the global intravenous solution market include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited.
Report Description
Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, nonpyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others.
Market Dynamics
Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, according to the World Health Organization (WHO), in May 2017, there were around 1.7 billion annual cases of childhood diarrheal disease across the globe.
Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016.
Increasing cost of vitamin C intravenous therapy is expected to hinder the global intravenous solution market growth. For instance, in 2017, the China government took regulatory action of lowering vitamin C production owing to environmental concerns. This led to increase in prices of vitamin C by around 300% over the year. Furthermore, China produces 95% of the world’s vitamin C, which is used in food products, dietary supplements, and pharmaceuticals. The price of vitamin C was US$ 3.50 per kg in October 2016, which increased to US$ 12 per kg by September 2017, owing to environmental issues, which decreased China’s 30% of the vitamin C production.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 34 market data tables and 35 figures on "Intravenous Solution Market” - Global forecast to 2027”
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Contact Us
